UCC Innovation’s Post

Backstage Biotechmed 2023 “Biotechmed – 2023” became one of the most productive, and its results continue to be discussed after the forum. Deputy Head of the Russian Federation - Minister of Industry and Trade Denis Manturov: “Today we set ourselves the task and goal of providing ourselves with our own components, our own substances from our state. Everything that is presented at the BIOTECHMED exhibition meets the goal of technological independence in the field of pharmaceuticals, medical devices and medical equipment.” https://lnkd.in/ezpha2R9

How do pharmaceutical companies ensure the compatibility of their medications with digital therapeutics and wearable technologies? Read our latest blog to know more. 🔗https://lnkd.in/gt9hDiai #DigitalSuccess #INTblogs

🚀 Exciting News from LumiRx! 🚀 At LumiRx, we're on the brink of revolutionizing the pharmaceutical industry with our cutting-edge NFC chip technology. As we gear up for our launch in the coming months, we want to share how our innovation is set to transform medicine tracking and tracing like never before. Our NFC chips are designed with two core objectives: ensuring full DSCSA compliance and opening new doors for manufacturers to connect with their customers directly. This means not only will medication safety and authenticity be significantly enhanced, but pharmaceutical companies will gain invaluable insights into consumer behavior and preferences. We're thrilled about the possibilities and can't wait to bring this technology to you. Stay tuned for more updates and get ready to be part of the change that shapes the future of medicine security and customer engagement. #Innovation #Pharmaceuticals #NFC #TechRevolution #DSCSACompliance #CustomerInsight #LumiRxLaunch #FutureOfMedicine

Utilized to sterilize billions of medical devices each year, electron beam (E-beam) irradiation utilizes high-energy electrons produced by normal electrical current that is accelerated to near the speed of light by means of an accelerator. Learn more about E-beam sterilization at STERIS, as well as its benefits and uses, at https://lnkd.in/exbeeVuv #STERISAST #HealthCare #HealthCareInnovation #Pharmaceuticals #Pharma #PharmaInnovation #BioTech #Manufacturing #MedicalDevices #ProductDevelopment #Sterilization #EBeam #PatientSafety #SupplyChain #ISOStandards #Innovation

Scientists have successfully patented a novel molecule with the potential to develop a safer diabetes drug. This breakthrough offers promising prospects for improved treatment options for diabetes patients, addressing concerns related to safety and efficacy. The patented molecule represents a significant advancement in diabetes research, signaling a step forward in the development of more effective and reliable pharmaceutical interventions for managing this chronic condition. Source: https://lnkd.in/gNz9gVQp Einfolge Technologies, a premier patent and intellectual property rights (IPR) firm in India, specializes in offering patent research and filing services specifically tailored for new medical technologies, novel molecules, and medical devices. Our expertise in this domain enables us to provide comprehensive support to innovators and businesses in navigating the complex landscape of patenting within the healthcare sector. For more details, visit: www.einfolge.com #patent #medicalpatent #medicaldevice #medicaltechnology #diabetesdrugpatent #patentfiling #patentmolecule #medicalinvention #innovation #patentlandscape #healthcaresector #patrnfilingprocedure #patentfilingservices #marketresearch #technologymarketresearch

16-18 october 2023 :IEEE R10 HTC 2023 International conference "Artificial Intelligence and Smart Technology for Humanity" and workshop on advance in "Molecular Medicine".#ieeeconference #pharmaceutical #molecularmedicine #moleculardocking #htc2023 #aiinhealthcare #artificialintelligenceinhealthcare #drugdiscovery #drugdevelopment

Auto-injector design should ideally be chosen to fit the properties of the drug, not the other way around. Simply put, the drug is too often developed to the injection device, based on crude assumptions rather than detailed facts about the capabilities of the device. In our experience, pharma companies risk missing the potential benefits of an optimal drug and device combination when the possibilities and limitations of an auto- injector platform are not fully understood. Do you agree? Check out our white paper on Platform Assessment: https://lnkd.in/e6mzAh27 #medtech #pharma #druganddevice #platformAssessment #combinationproducts #medicaldevice

🚨 Breaking News from LumiRx 🌍💊 We're thrilled to announce a major leap in our fight against counterfeit drugs worldwide! 🌐✨ LumiRx's innovative NFC chip technology is now at the forefront of ensuring drug authenticity and safety on a global scale. Our cutting-edge solution is more than just technology; it's a promise of reliability and trust in pharmaceuticals. With LumiRx chips embedded in drug packaging, consumers can instantly verify the authenticity of their medication with a simple tap of their smartphone. This breakthrough is not just about innovation; it’s about saving lives. 📱❤️ The impact? A drastic reduction in the circulation of counterfeit drugs, enhanced patient safety, and a significant boost in consumer confidence. We're proud to be setting a new standard in pharmaceutical safety and leading the charge in this crucial battle. 🛡️👥 Together, we're not just changing the market; we're revolutionizing it for a safer tomorrow. Let's embrace the future of healthcare with open arms! 🚀🌟 #LumiRx #HealthcareInnovation #PharmaceuticalSafety #CounterfeitDrugs #NFCtechnology #GlobalImpact

🌟 Exciting News! MDCG Releases Preliminary (Re-)Assessment Review Form Templates 🔬 The Medical Device Coordination Group (MDCG) has just released the preliminary (re-)assessment review form templates for MDCG 2024-6, 7, 8, and 9. This significant step forward reinforces commitment to excellence and compliance in the MedTech, Pharma, and BioTech industries. 📎 Access the documents here: MDCG 2024-6, 7, 8, and 9 🔍 Stay informed and ahead of the curve! 🚀 #MedTech #Pharma #BioTech #RegulatoryAffairs #MedicalDevices